Diebold Nixdorf, Incorporated (DBD) — QMA analysis
Sector: Technology · Market cap: $2.7B · Price: $69.18 · Data as of 2026-10-23
A composite score of 58/100 places Diebold Nixdorf, Incorporated in the neutral band, higher score than 89% of 22,734 tracked stocks. The highest-scoring layer is Fundamental value; the lowest is Insider activity.
What 12 data layers say about DBD
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 78/100 |
| Earnings quality (EQS) | 38/100 |
| Technical trend (TSS) | 45/100 |
| Relative strength (RS) | 43/100 |
| Momentum (USS) | 55/100 |
| Insider activity (IAS) | 37/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 67/100 |
| Institutional 13F (IFS) | 65/100 |
| Options flow (OFS) | 71/100 |
| News sentiment (NSS) | 57/100 |
| Analysts / transcripts (ATS) | 41/100 |
| Catalysts (XS) | 65/100 |
What does the QMA model currently show for Diebold Nixdorf, Incorporated?
The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.
For DBD the layers diverge — some score high (Fundamental value), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
DBD insider & smart money activity
Over the recent period we record 2 reported insider purchases and 9 sales for DBD: predominance of reported sales (by dollar value). A description of the data layer, not an instruction.
DBD dividend
Diebold Nixdorf, Incorporated currently carries a dividend yield of 0.14% and has paid for 37 years in a row.
How DBD compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for DBD stock?
58/100 (grade B) as of 2026-10-23, fusing 12 data layers. An analytical score, not advice.
Are insiders buying DBD stock?
Over the recent period, reported: purchases 2, sales 9 (purchases $100K, sales $50M). Insider activity: predominance of reported sales (by dollar value) — a description of reported data, not a trade instruction.
Where can I see live DBD data?
Live DBD data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Explore more — for free
The DBD score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.
Want the full DBD analysis with all layers and live data? Open DBD detail →
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]